Corporate Social Responsibility Report

The report describes Genmab’s 2017 CSR activities across employee well-being, ethics in pre-clinical and clinical studies, environmental management, and business ethics and transparency. It reports that female board membership increased to 33% following the 2017 Annual General Meeting. The report also highlights employee engagement and security initiatives, while stating that no environmental indicators were included because the company considered its environmental impact limited.